Issue 104 • March 2021

HeLa: the legacy of Henrietta Lacks

Treating Covid-19 symptoms in the GI tract

A history of antibody-drug conjugates

Getting the skinny on generics labelling

An ongoing court battle over skinny labelling practices could mean trouble for the future of generics manufacturers

02/23/2024 23:26:12

02/17/2021 00:00:00

Go to article: Home | Getting the skinny on generics labelling Go to article: In this issue Go to article: Contents Go to article: HOF Sonderanlagenbau Company Insight Go to article: HOF Sonderanlagenbau Go to article: Briefing Go to article: Industry news Go to article: The pharma industry briefing Go to article: Covid-19 executive briefing by GlobalData Go to article: Mimotopes Company Insight Go to article: Mimotopes Go to article: The Solubility company Go to article: The Solubility Company Insight Go to article: Comment Go to article: Market access of orphan designated therapies at risk Go to article: Lodo Therapeutics’ AI-driven natural drug discovery platform Go to article: Concert Pharmaceuticals discontinues schizophrenia drug after trial failure Go to article: Medical cannabis in Europe: a compelling opportunity Go to article: Exploring the pharma deals outlook in 2021 Go to article: In Depth Go to article: Skinny labelling of generics: the beginning of the end for this practice?Go to article: Charting the choppy history of ‘magic bullet’ antibody-drug conjugates Go to article: How a sleeping drug awakened a patient with akinetic mutism Go to article: Breast cancer research: addressing the pre-menopausal problem Go to article: Beyond the lung: treating the GI symptoms of Covid-19 Go to article: Immortal cells and informed consent: the legacy of Henrietta Lacks Go to article: How radiopharmaceuticals are helping fight cancer with Fusion Go to article: Competition heats up as new HIV prevention drug shows promise Go to article: Baxter Go to article: ACG Worldwide Go to article: In Data Go to article: Inside the deal Go to article: Deals analysis Go to article: The pharma industry key list Go to article: Global markets and indices Go to article: Macro-economic indicators Go to article: Macro-economic indicators (page 2)Go to article: Events Go to article: Next issue